Equities
IndustrialsElectronic & Electrical Equipment
  • Price (USD)216.72
  • Today's Change0.22 / 0.10%
  • Shares traded151.22k
  • 1 Year change-7.56%
  • Beta1.0853
Data delayed at least 15 minutes, as of Feb 19 2020 17:36 GMT.
More ▼

Profile data is unavailable for this security.

About the company

Waters Corporation is an analytical instrument manufacturer. The Company operates through two segments: Waters and TA. It designs, manufactures, sells and services high performance liquid chromatography (HPLC), ultra performance liquid chromatography (UPLC and together with HPLC, referred to as LC) and mass spectrometry (MS) technology systems and support products, including chromatography columns, other consumable products and post-warranty service plans. It also designs, manufactures, sells and services thermal analysis, rheometry and calorimetry instruments through its TA product line. It is also a developer and supplier of software-based products that interface with the Company's instruments, as well as other suppliers' instruments. Its LC and LC-MS instruments are utilized in a range of industries to detect, identify, monitor and measure the chemical, physical and biological composition of materials, and to purify a range of compounds.

  • Revenue in USD (TTM)2.41bn
  • Net income in USD588.97m
  • Incorporated1991
  • Employees7.20k
  • Location
    Waters Corp34 MAPLE STMILFORD 01757-3604United StatesUSA
  • Phone+1 (508) 478-2000
  • Fax+1 (508) 872-1990
  • Websitehttp://www.waters.com
More ▼

Mergers & acquisitions

Acquired companyDeal statusDateDate /
Deal status
WAT:NYQ since
announced
Transaction
value
Andrew Alliance SAAnnounced13 Jan 202013 Jan 2020Announced-6.13%--
Data delayed at least 15 minutes, as of Feb 19 2020 17:36 GMT.

Peer analysis

Key Information
CompanyRevenue (TTM)Net income (TTM)Market capEmployeesPrice/earnings (TTM)Price/book value (MRQ)Price/cash flow (TTM)Price/sales (TTM)EPS (excl. extraordinary items, TTM)EPS (incl. extraordinary items, TTM)Revenue per share (TTM)Book value per share (MRQ)Asset turnover (TTM)Inventory turnover (TTM)Receivables turnover (TTM)Revenues per employee (TTM)Return on avg assets (TTM)Return on avg assets (5 yr avg)Return on investment (TTM)Return on investment (5 yr avg)Gross margin (TTM)Gross margin
(5 yr avg)
Net profit margin (TTM)Net Profit margin
(5 yr avg)
Quick ratio (MRQ)Interest coverage (TTM)Total debt to capital (MRQ)Payout ratio
(5 yr avg)
Revenue
(YOY change %)
Revenue
(5 yr growth rate)
Net income
(YOY change %)
Net income
(5 yr growth rate)
Capital expenditure
(5 yr growth rate)
Dividend
(5 yr growth rate)
Integra Lifesciences Holdings Corp1.51bn60.02m5.05bn4.50k84.923.6428.993.350.69260.692617.4716.140.46151.825.68334,610.001.842.722.012.9964.0564.893.995.381.925.750.50780.0023.9211.98-43.78--10.19--
MKS Instruments, Inc.1.90bn140.32m6.21bn4.85k44.793.0724.793.272.542.5434.4637.120.63012.535.97--4.6510.185.1511.3243.7145.377.3913.793.066.730.30417.81-8.4519.46-64.213.9337.124.08
Hill-Rom Holdings, Inc.2.91bn149.80m7.30bn10.00k49.094.5022.992.512.222.2243.0424.180.6565.105.14290,880.003.383.034.043.6349.3947.765.154.831.173.940.552237.192.0811.51-16.6920.067.626.88
Bruker Corporation2.03bn206.70m7.58bn6.87k37.388.9726.993.741.321.3212.905.490.95551.915.94294,949.109.776.9013.829.9047.9645.1810.227.461.3217.730.372111.947.340.603721.8317.54-0.4413--
Cognex Corporation725.63m203.87m8.79bn2.27k43.816.4838.4412.121.161.164.147.860.4572.646.16320,081.6012.8416.6713.7617.9773.8575.0928.1029.784.54--0.0014.27-10.0111.22-11.4812.960.7631--
Avantor Inc6.04bn-335.10m10.09bn12.00k--6.9223.101.67-0.635-0.63510.874.300.61375.966.25503,358.300.384--0.4317--31.80--0.6258--1.221.210.6751--3.00---2.51------
PerkinElmer, Inc.2.88bn227.75m10.46bn12.50k46.113.7223.683.632.042.0425.8625.330.46074.284.25--3.644.384.155.0848.4147.697.909.321.327.370.424313.713.805.21-3.277.1624.530.00
Bio-Rad Laboratories, Inc.2.31bn1.76bn12.18bn8.26k7.002.126.435.2758.2458.2476.86192.250.33951.855.89--25.839.8028.6811.0254.4954.7176.0820.891.80--0.071--0.97161.23455.4681.68----
Allegion PLC2.85bn401.80m12.48bn11.00k31.5316.4525.744.374.264.2630.268.170.9885.828.72--13.9212.3916.9515.3843.8843.6714.0912.441.4410.400.652521.304.486.14-2.7116.624.9627.54
Waters Corporation2.41bn588.97m13.95bn7.20k24.81--20.105.808.738.7735.26-3.320.76593.304.16--18.7412.9528.3515.3158.0058.8324.4724.200.550126.991.15---0.5513.88-1.056.419.05--
Mettler-Toledo International Inc.3.01bn561.11m18.09bn16.20k33.4043.1327.856.0122.5222.52120.4717.441.114.675.46185,719.3020.7519.3528.6326.9157.8757.4018.6516.671.1119.640.75420.002.493.898.7010.651.72--
Keysight Technologies Inc4.30bn590.00m19.03bn13.60k31.576.0921.204.423.093.2522.5616.020.69142.676.66316,397.109.487.2611.828.9558.8955.7213.7110.132.5011.760.37310.0010.967.97276.369.6411.38--
Data as of Feb 19 2020. Currency figures normalised to Waters Corp's reporting currency: US Dollar USD

Institutional shareholders

52.82%Per cent of shares held by top holders
HolderShares% Held
The Vanguard Group, Inc.as of 31 Dec 20197.22m11.20%
Massachusetts Financial Services Co.as of 31 Dec 20195.62m8.72%
Fundsmith LLPas of 31 Dec 20195.11m7.93%
BlackRock Fund Advisorsas of 31 Dec 20193.78m5.87%
Walter Scott & Partners Ltd.as of 31 Dec 20193.43m5.32%
SSgA Funds Management, Inc.as of 31 Dec 20192.90m4.50%
Baillie Gifford & Co.as of 31 Dec 20192.37m3.68%
Janus Capital Management LLCas of 30 Sep 20191.64m2.55%
Champlain Investment Partners LLCas of 31 Dec 2019998.58k1.55%
Geode Capital Management LLCas of 31 Dec 2019979.63k1.52%
More ▼
Data from 30 Sep 2019 - 31 Dec 2019Source: FactSet Research Systems Inc.
The Financial and Risk business of Thomson Reuters is now Refinitiv
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.